According to a new market report by Lucintel, the future of the electrophysiology market looks promising with opportunities in the hospitals, emergency clinics, cardiac centers, diagnostic centers, and healthcare providers. The global electrophysiology market is expected to grow with a CAGR of 10% from 2019 to 2024. The major drivers for this market are technological advancements, growing prevalence of atrial fibrillation, rapid growth in aging population with higher risk of target diseases, and increasing burden of cardiovascular diseases across the globe.
In this market, EP ablation catheters, diagnostic catheters, and EP laboratory devices are the major devices used in electrophysiology. On the basis of comprehensive research, EP ablation catheters will remain the largest segment and is also expected to witness highest growth during forecast period due to growing preference of catheter ablation for the treatment of cardiac arrhythmias and increased adoption by the physicians.
North America will remain the largest market over the forecast period due to rise in prevalence of cardiac arrhythmias and increase in geriatric population, and high adoption rate of technologically advanced electrophysiology devices.
Abbott Laboratories, Biosense Webster, Biotronik, Boston Scientific, GE Healthcare, Koninklijke Philips, Medtronic, Microport Scientific, St. Jude Medical, and Siemens are among the major manufacturers of electrophysiology market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global electrophysiology market by application, product type, indication, end user, and region. Lucintel has prepared a comprehensive research report entitled "Global Electrophysiology Market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global electrophysiology market by application, product type, indication, end user, and region as follows:
By Application [$M shipment analysis for 2013 – 2024]:
Electrophysiology Treatment Devices
Electrophysiology Monitoring Devices
By Device Type [$M shipment analysis for 2013 – 2024]:
EP Diagnostic Catheters
EP Laboratory Devices
EP Ablation Catheters
Access Devices
By Indication [$M shipment analysis for 2013 – 2024]:
Atrial Fibrillation
Ventricular Fibrillation
Atrioventricular Nodal Reentry Tachycardia
Wolff-Parkinson-White (WPW)
Right Atrial Tachycardia
Right Atrial Flutter
Left Atrial Flutter
Right Ventricular Tachycardia
Left Ventricular Tachycardia
By End-User [$M shipment analysis for 2013 – 2024]:
Hospitals
Emergency Clinics
Cardiac Centers
Diagnostic Centers
Healthcare Providers
By Region [$M shipment analysis for 2013 – 2024]:
United States
Canada
Mexico
United kingdom
Germany
France
Italy
Spain
This research report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.